Polymer‐encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP‐2, and induce osteogenic and angiogenic tissue formation
- 1 October 2002
- journal article
- research article
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 13 (10-12) , 863-870
- https://doi.org/10.1002/pat.231
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Exogenously Regulated Stem Cell-Mediated Gene Therapy for Bone RegenerationMolecular Therapy, 2001
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Delivery of Recombinant Gene Product to Canines with Nonautologous Microencapsulated CellsHuman Gene Therapy, 1998
- Effects of BMP-2, BMP-4, and BMP-6 on Osteoblastic Differentiation of Bone Marrow-Derived Stromal Cell Lines, ST2 and MC3T3-G2/PA6Biochemical and Biophysical Research Communications, 1996
- Growth of recombinant fibroblasts in alginate microcapsulesBiotechnology & Bioengineering, 1994
- Transplantation of a Polymer-Encapsulated Cell Line Genetically Engineered to Release NGFExperimental Neurology, 1993
- A Novel Synthetic Method for Hybridoma Cell EncapsulationNature Biotechnology, 1991
- Alginate as immobilization matrix for cellsTrends in Biotechnology, 1990
- Microencapsulation of Mammalian Cells in A Hydroxyethyl Methacrylate-Methyl Methacrylate Copolymer: Preliminary DevelopmentBiomaterials, Artificial Cells and Artificial Organs, 1988